CLDN18 and cancer: Finally, we showed a non-significant trend towards a worse cancer-specific survival in CLDN18-positive SBAs, as reported in CRC [27], even though very discordant data are reported in the Literature for other gastrointestinal cancers [25 26 28 37 42 47 48].